haploidentical donor hematopoietic progenitor cell and NK cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for haploidentical donor hematopoietic progenitor cell and NK cell transplantation, covering 2022-10-31 to 2022-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy [Phase 2]